Eagle Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 80 pages Dated 27 March 2022 Eagle Pharmaceuticals, Inc. and Acacia Pharma Group PLC Co-Operation Agreement Relating to the Proposed Scheme of Arrangement of Acacia Pharma Group PLC

from 8-K 34 pages Recommended Scheme of Arrangement of Acacia Pharma Group PLC by Eagle Pharmaceuticals, Inc. to Be Effected by Means of a Scheme of Arrangement Under Part 26 of the Companies Act 2006

from 8-K 4 pages Amendment No. 1 to Stock Purchase Agreement

from 8-K 85 pages Stock Purchase Agreement by and Among Eagle Pharmaceuticals, Inc. (As “Buyer”), Arsia Therapeutics, LLC (The “Seller”), Arsia Therapeutics, Inc. (The “Company”), Amy Schulman (Solely in Her Capacity as “Seller Representative”), and the Parties That Execute the Joinder Agreements (The “Equityholder Indemnitors”) November 10, 2016

from SC 13D ~5 pages Schedule of Transactions Effected During the Last 60 Days